Steward Partners Investment Advisory, LLC Biotechnology

Steward Partners Investment Advisory, LLC

$12.3 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
HALO Halozyme Therapeutics, Inc.	$8.95B	$12,000 0.0% of portfolio	244	Q2 2025 Reduced 55.15%
ARVN Arvinas, Inc.	$361M	$11,000 0.0% of portfolio	1,600	Q1 2025 New
OCUL Ocular Therapeutix, Inc	$961M	$10,000 0.0% of portfolio	1,108	Q2 2025 Added 10.8%
JAZZ Jazz Pharmaceuticals PLC	$7.1B	$10,000 0.0% of portfolio	102	Q2 2025 Reduced 5.56%
DRTS Alpha Tau Medical Ltd.	$235M	$10,000 0.0% of portfolio	3,300	Q2 2025 Reduced 7.04%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.88B	$9,000 0.0% of portfolio	605	Q4 2024 Added 98.36%
SRRK Scholar Rock Holding Corp	$1.66B	$9,000 0.0% of portfolio	276	Q1 2025 New
CGEN Compugen LTD	$127M	$9,000 0.0% of portfolio	5,202	Q2 2024 Added 48.63%
NTLA Intellia Therapeutics, Inc.	$825M	$7,000 0.0% of portfolio	767	Q2 2025 Added 60.8%
WVE Wave Life Sciences Ltd.	$734M	$7,000 0.0% of portfolio	1,200	Q2 2025 Added 14.29%
LGND Ligand Pharmaceuticals Inc	$2.58B	$6,000 0.0% of portfolio	61	Q1 2025 New
BEAM Beam Therapeutics Inc.	$1.19B	$5,000 0.0% of portfolio	300	Q4 2023 New
BCRX Biocryst Pharmaceuticals Inc	$1.55B	$5,000 0.0% of portfolio	600	Q1 2025 New
GERN Geron Corp	$510M	$5,000 0.0% of portfolio	4,000	Q2 2024 Added 100.0%
HRMY Harmony Biosciences Holdings, Inc.	$2.1B	$5,000 0.0% of portfolio	170	Q3 2024 New
INVA Innoviva, Inc.	$1.4B	$5,000 0.0% of portfolio	266	Q2 2025 New
SWTX Spring Works Therapeutics, Inc.	$2.93B	$4,000 0.0% of portfolio	100	Q2 2025 Reduced 20.63%
IMCR Immunocore Holdings PLC	$1.4B	$3,000 0.0% of portfolio	100	Q2 2025 Reduced 10.71%
NVAX Novavax Inc	$663M	$3,000 0.0% of portfolio	530	Q1 2025 Reduced 14.38%
ATNM Actinium Pharmaceuticals, Inc.	$38M	$2,000 0.0% of portfolio	2,000	Q3 2024 New
ANVS Annovis Bio, Inc.	$22.6M	$2,000 0.0% of portfolio	1,000	Q1 2025 New
BDTX Black Diamond Therapeutics, Inc.	$92.3M	$2,000 0.0% of portfolio	1,200	Q1 2025 Reduced 20.79%
HRTX Heron Therapeutics, Inc.	$156M	$2,000 0.0% of portfolio	1,000	Q4 2024 Reduced 9.91%
SRPT Sarepta Therapeutics, Inc.	$1.6B	$2,000 0.0% of portfolio	170	Q2 2025 Reduced 37.5%
SNDX Syndax Pharmaceuticals Inc	$734M	$2,000 0.0% of portfolio	231	Q4 2023 New
BYSI Beyond Spring Inc.	$78.2M	$2,000 0.0% of portfolio	1,080	Q1 2025 New
ENLV Enlivex Therapeutics Ltd.	$28.9M	$2,000 0.0% of portfolio	2,500	Q4 2024 Reduced 16.67%
PRQR Pro Qr Therapeutics N.V.	$136M	$2,000 0.0% of portfolio	1,300	Q2 2025 Added 100.0%
ARQT Arcutis Biotherapeutics, Inc.	$887M	$1,000 0.0% of portfolio	113	Q2 2025 New
ASND Ascendis Pharma A/S	$10.9B	$1,000 0.0% of portfolio	7	Q2 2025 New
AXSM Axsome Therapeutics, Inc.	$4.51B	$1,000 0.0% of portfolio	10	Q2 2025 Added 150.0%
DAWN Day One Biopharmaceuticals, Inc.	$451M	$1,000 0.0% of portfolio	300	Q1 2025 New
EDIT Editas Medicine, Inc.	$157M	$1,000 0.0% of portfolio	525	Q4 2024 Added 23.53%
FDMT 4 D Molecular Therapeutics, Inc.	$199M	$1,000 0.0% of portfolio	500	Q1 2025 New
GMAB Genmab A/S	$14.4B	$1,000 0.0% of portfolio	80	Q3 2024 Added 5.26%
GOSS Gossamer Bio, Inc.	$181M	$1,000 0.0% of portfolio	1,000	Q4 2024 New
VIR Vir Biotechnology, Inc.	$578M	$1,000 0.0% of portfolio	300	Q1 2025 New
VYGR Voyager Therapeutics, Inc.	$131M	$1,000 0.0% of portfolio	400	Q4 2021 Reduced 81.4%
AGIO Agios Pharmaceuticals, Inc.	$1.94B	$0 0.0% of portfolio	9	Q1 2020 Reduced 99.01%
ACLX Arcellx, Inc.	$3.19B	$0 0.0% of portfolio	7	Q2 2025 New
SAVA Cassava Sciences Inc	$93M	$0 0.0% of portfolio	112	Q4 2024 Added 49.33%
ERAS Erasca, Inc.	$191M	$0 0.0% of portfolio	200	Q1 2025 New
MDGL Madrigal Pharmaceuticals, Inc.	$6.14B	$0 0.0% of portfolio	1	Q1 2025 New
NVCT Nuvectis Pharma, Inc.	$100M	$0 0.0% of portfolio	100	Q2 2024 New
OCGN Ocugen, Inc.	$223M	$0 0.0% of portfolio	405	Q1 2022 New
PGEN Precigen, Inc.	$375M	$0 0.0% of portfolio	600	Q1 2025 Reduced 0.17%
RPTX Repare Therapeutics Inc.	$65.4M	$0 0.0% of portfolio	11	Q1 2025 New
SLN Silence Therapeutics PLC	$201M	$0 0.0% of portfolio	100	Q4 2021 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	128,180	Q2 2025 Added 164.4%
VCEL Vericel Corp	$1.72B	$0 0.0% of portfolio	20	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.